10^th World Congress on Pharmacology August 02-03, 2018 Barcelona, Spain

Karen Mulkijanyan is the Head of the Department of Pharmacology at Tbilisi State Medical University Institute of Pharmacochemistry and Adviser on Technology Commercialization to aforesaid Institute’s Administration. He obtained his MS in Biochemistry in 1981 and PhD in Pharmacy in 2005. Dr. Mulkijanyan’s research interests include studying the pharmacology of anti-inflammatory and wound healing drugs and analysis and prediction of structure-activity relationship of natural, modified and synthesized compounds. He is the author and co-author of more than 90 papers in peer-reviewed journals, about 30 presentations at international scientific meetings, and 2 patents.

Pharmacology of antiinflammatory, wound healing and microcirculatory drugs. Pharmacokinetics. Toxicology. Analysis and prediction of structure-activity relationship of natural, modified and synthesized compounds.

Tejani-Butt teaches courses in central nervous system physiology and pharmacology, special topics in Neuropsychopharmacology, endocrine physiology and pharmacology and drug-receptor interactions. She is a member of many national and local organizations, including the Society for Neuroscience, World Women in Neuroscience, and served on NIH expert panel of Grant study section for several years. She has been the recipient of extramural funding from NIH, foundations and pharmaceutical companies for the past 25 years.

Neuropsychopharmacology, alcohol and substance abuse, stress and psychiatric disorders Molecular Mechanisms associated with the regulation of biogenic amines in an animal model of depressive behavior; implication of these biogenic amines in modulating a stress response, reward and addictive behaviors, as well as in the therapeutic action of drugs used to treat psychiatric disorders.

Sandra H. P. Oliveira obtained bachelor's degree in Biological Sciences (Biomedicine) from the Federal University of the State of Rio de Janeiro (1988), a Master's degree in Cellular and Molecular Biology in the area of ​​Pharmacology from the Oswaldo Cruz Foundation (1994) and a PhD in Pharmacology from the School of Medicine of Ribeirão Preto, University of São Paulo (1998). She completed postdoctoral studies at the University of Michigan in the field of immunopharmacology (2000). She is currently Adjunct Professor at the Faculty of Dentistry of Araçatuba, São Paulo State University "Júlio de Mesquita Filho", local vice-coordinator of the Multicentric Postgraduate Program in Physiological Sciences. She was a full member of the Central Postgraduate Chamber of UNESP.

Will be updated soon

Maria V Tejada-Simon is an Associate Professor of Pharmacology, Biology and Psychology, and member of the Biology of Behavior Institute at the University of Houston in Houston, Texas. Current research in her laboratory examines the role of small GTP-binding proteins in cognition, with emphasis in mental retardation, schizophrenia, neurodegenerative as well as autistic disorders.

• Small GTPases in LTP, hippocampus-dependent learning and memory. • Implication of small GTPases in defective synaptic plasticity. • Rac1-dependent regulation of neuronal morphology in cognitive disabilities. • Therapeutic potential of small GTPase inhibition in Fragile X syndrome